Healthy Skepticism Library item: 3042

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Rheinstein P, Baum CS.
Labeling effectiveness and the health environment
1980; 6:275-287

Abstract:

This chapter examines product labeling as it applies to the area of prescription drug promotion. It outlines the role of the Food and Drug Administration in drug labeling and the various methods of drug promotion concentrating on sales representatives and journal advertising but also briefly mentioning direct mailing, continuing medical education and convention exhibits. In addition to promotional activities directed specifically to health practitioners, pharmaceutical manufacturers are concerned with more general publicity that may be given to their products. This aspect is discussed with reference to the activities of on manufacturer around the question of estrogen replacement and uterine cancer.

Keywords:
*analysis/United States/sales representatives/journal advertisements/continuing medical education/direct mail/ convention exhibits/regulation of promotion/Food and Drug Administration/FDA/ labeling/ATTITUDES REGARDING PROMOTION: REGULATORS AND GOVERNMENT/EVALUATION OF PROMOTION: DETAILING/EVALUATION OF PROMOTION: DIRECT MAIL/EVALUATION OF PROMOTION: JOURNAL ADVERTISEMENTS/EVALUATION OF PROMOTION: LABELLING AND PACKAGE INSERTS/PROMOTION DISGUISED: PRESS CONFERENCES AND PRESS COVERAGE/PROMOTIONAL TECHNIQUES: CONFERENCE EXHIBITS /PROMOTIONAL TECHNIQUES: PUBLIC RELATIONS/REGULATION, CODES, GUIDELINES: DIRECT GOVERNMENT REGULATION